诺泰生物(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688076 诺泰生物

已收盘 11-15 15:00:00

{"stockData":{"symbol":"688076","market":"SH","secType":"STK","nameCN":"诺泰生物","latestPrice":54.22,"timestamp":1731654000000,"preClose":55.28,"halted":0,"volume":4801406,"delay":0,"floatShares":220000000,"shares":220000000,"eps":1.9177,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.06,"latestTime":"11-15 15:00:00","open":55,"high":55.79,"low":54,"amount":263000000,"amplitude":0.0324,"askPrice":54.23,"askSize":72,"bidPrice":54.22,"bidSize":15,"shortable":0,"etf":0,"ttmEps":1.9177,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731893400000},"adr":0,"adjPreClose":55.28,"symbolType":"stock_kcb","openAndCloseTimeList":[[1731634200000,1731641400000],[1731646800000,1731654000000]],"highLimit":60.81,"lowLimit":49.75,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":219779883,"pbRate":4.68,"roa":"--","roe":"14.63%","epsLYR":0.76,"committee":-0.196203,"marketValue":11916000000,"floatMarketCap":11916000000,"peRate":28.273452,"changeRate":-0.0192,"turnoverRate":0.0218,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-11-18。","afterMarket":{"amount":0,"volume":0,"close":54.22,"buyVolume":0,"sellVolume":0,"time":1731656039464,"indexStatus":"已收盘 11-15 15:30:00","preClose":55.28}},"requestUrl":"/m/hq/s/688076","defaultTab":"news","newsList":[{"id":"2482071638","title":"诺泰生物大幅上涨 生物医药产业蓬勃发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2482071638","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482071638?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:21","pubTimestamp":1731378060,"startTime":"0","endTime":"0","summary":"11月12日，诺泰生物股价大幅上涨，截至10点21分，诺泰生物上涨5.03%，报59.09元/股，成交3.22亿元，换手率2.53%。资金动向截止发稿，诺泰生物获得主力净流入5106万元，其中超大单流入2896万元，大单流入2209万元。主营业务及业绩诺泰生物公司主营业务为多肽药物及小分子化药进行自主研发与定制研发生产。最新财报显示，今年三季报，诺泰生物实现营业收入12.52亿元，同比增长76.51%，净利润为3.50亿元，同比增长281.90%，基本每股收益为1.62元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112102158abb7b4ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112102158abb7b4ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["399441","161726","BK0239","688076"],"gpt_icon":0},{"id":"2482124279","title":"11月11日诺泰生物涨7.04%，南方医药保健灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482124279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482124279?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:09","pubTimestamp":1731312549,"startTime":"0","endTime":"0","summary":"证券之星消息，11月11日诺泰生物涨7.04%，收盘报56.26元，换手率5.87%，成交量12.9万手，成交额7.05亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共56家，其中持有数量最多的公募基金为南方医药保健灵活配置混合A。南方医药保健灵活配置混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100019591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2482279486","title":"诺泰生物涨7.04%，国金证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2482279486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482279486?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:09","pubTimestamp":1731312540,"startTime":"0","endTime":"0","summary":"今日诺泰生物（688076）涨7.04%，收盘报56.26元。2024年10月23日，国金证券研究员赵海春,袁维发布了对诺泰生物的研报《多肽发力持续，前三季度净利润同比增3倍》，该研报对诺泰生物给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为76.59%。此外，民生证券研究员王班,乔波耀，东海证券研究员杜永宏,伍可心近期也对该股发布了研报，同样给出“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为广发证券的方程嫣、罗佳荣。诺泰生物（688076）个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100019587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076"],"gpt_icon":0},{"id":"2482227669","title":"诺泰生物11月11日收涨7.04% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2482227669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482227669?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:21","pubTimestamp":1731309706,"startTime":"0","endTime":"0","summary":"11月11日, 诺泰生物股价涨7.04%，报收56.26元，成交金额7.05亿元，换手率5.87%，振幅9.97%，量比1.59。诺泰生物今日主力资金净流出3827万元，上一交易日主力净流入4983万元。该股近5个交易日上涨13.43%，主力资金累计净流入27万元；近20日主力资金累计净流出8138万元，其中净流出天数为14日。净流出前三个股分别为爱尔眼科、美年健康、诺泰生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111153935a22bc037&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111153935a22bc037&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2482226841","title":"诺泰生物大幅上涨 青海省医保局调整检验类项目价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2482226841","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482226841?lang=zh_cn&edition=full","pubTime":"2024-11-11 13:10","pubTimestamp":1731301817,"startTime":"0","endTime":"0","summary":"11月11日，诺泰生物股价大幅上涨，截至13点10分，诺泰生物上涨5.02%，报55.20元/股，成交4.16亿元，换手率3.53%。资金动向截止发稿，诺泰生物获得主力净流入1450万元，其中超大单流入1391万元，大单流入58万元。主营业务及业绩诺泰生物公司主营业务为多肽药物及小分子化药进行自主研发与定制研发生产。最新财报显示，今年三季报，诺泰生物实现营业收入12.52亿元，同比增长76.51%，净利润为3.50亿元，同比增长281.90%，基本每股收益为1.62元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131109abb4bfa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131109abb4bfa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2481759928","title":"诺泰生物11月07日遭主力抛售1159万元 环比增加393.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481759928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481759928?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:18","pubTimestamp":1730963899,"startTime":"0","endTime":"0","summary":"11月07日, 诺泰生物股价涨1.36%，报收51.53元，成交金额2.97亿元，换手率2.64%，振幅3.11%，量比0.59。诺泰生物今日主力资金净流出1159万元，上一交易日主力净流出235万元，今日环比增加393.19%。该股近5个交易日上涨6.14%，主力资金累计净流出374万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1.03亿元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152816a21f88f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152816a21f88f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2481661950","title":"诺泰生物任命黎晌博士为首席投资官（CIO）","url":"https://stock-news.laohu8.com/highlight/detail?id=2481661950","media":"诺泰生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481661950?lang=zh_cn&edition=full","pubTime":"2024-11-06 09:00","pubTimestamp":1730854832,"startTime":"0","endTime":"0","summary":"近日，江苏诺泰澳赛诺生物制药股份有限公司宣布，任命黎晌博士为首席投资官，负责公司产业布局与投资业务。诺泰生物董事长童梓权表示，黎晌博士的加盟，势必将为公司业务板块的巩固与拓展、国际化战略的推进，以及持续保持并激发企业的创新活力，起到举足轻重的关键作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106120753aba423c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106120753aba423c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2480090773","title":"诺泰生物（688076）10月31日主力资金净卖出7834.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480090773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480090773?lang=zh_cn&edition=full","pubTime":"2024-11-01 08:19","pubTimestamp":1730420366,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月31日收盘，诺泰生物报收于48.55元，下跌6.27%，换手率6.48%，成交量14.24万手，成交额7.04亿元。近5日资金流向一览见下表：诺泰生物融资融券信息显示，融资方面，当日融资买入6080.53万元，融资偿还5705.85万元，融资净买入374.67万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100009604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2479079747","title":"诺泰生物（688076）可能涉及技术转让被证监会立案，股民可索赔","url":"https://stock-news.laohu8.com/highlight/detail?id=2479079747","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479079747?lang=zh_cn&edition=full","pubTime":"2024-10-31 13:38","pubTimestamp":1730353080,"startTime":"0","endTime":"0","summary":"　　2024年10月23日晚间，诺泰生物（维权）发布公告称公司及实际控制人之一赵德中因涉嫌信息披露违法违规，收到中国证监会的《立案告知书》。经公司自查，本次立案可能涉及公司2021年度技术转让相关事宜，但截至目前尚未披露更多细节。　　技术转让是诺泰生物的主营业务之一，虽然公司有多种技术服务转让方式，但对于2021年度的某些技术转让项目，在信息披露上可能存在关键交易细节未明确、不完整的情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-31/doc-incummvz5989746.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-31/doc-incummvz5989746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2479742827","title":"诺泰生物大跌5.02% 3家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2479742827","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479742827?lang=zh_cn&edition=full","pubTime":"2024-10-31 13:16","pubTimestamp":1730351771,"startTime":"0","endTime":"0","summary":"10月31日，诺泰生物股价大幅下跌，截至13点16分，诺泰生物下跌5.02%，报49.20元/股，失守50元整数关口，成交3.30亿元，换手率2.98%。此外，数据统计显示，近半年内3家券商给予增持建议，25家券商给予买入建议。资金动向截止发稿，诺泰生物获得主力净流出2791万元，其中超大单流出2879万元，大单流入88万元。最新财报显示，今年三季报，诺泰生物实现营业收入12.52亿元，同比增长76.51%，净利润为3.50亿元，同比增长281.90%，基本每股收益为1.62元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031131632a1ff40f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031131632a1ff40f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2479799195","title":"三家药企实控人被证监会立案！","url":"https://stock-news.laohu8.com/highlight/detail?id=2479799195","media":"经参证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479799195?lang=zh_cn&edition=full","pubTime":"2024-10-31 07:57","pubTimestamp":1730332638,"startTime":"0","endTime":"0","summary":"“近期，A股多家医药生物行业公司（依据申万一级行业分类）集中宣布被中国证监会立案调查，其中既有“减肥药概念”明星股诺泰生物，又有刚于今年6月“摘帽”的南卫股份，还包括实控人屡被处罚的四环生物。《经济参考报》记者注意到，在前述三家公司中，诺泰生物及实际控制人赵德中系因涉嫌信息披露违法违规等被立案；南卫股份控股股东及实际控制人李平、财务总监项琴华系因涉嫌内幕交易被立案；四环生物实际控制人陆克平系因涉嫌","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031075939a1fd9806&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031075939a1fd9806&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0177","BK0239","688076","603880"],"gpt_icon":0},{"id":"2479940953","title":"“资本高手”马失前蹄！百亿诺泰生物被投资者和律师盯上了","url":"https://stock-news.laohu8.com/highlight/detail?id=2479940953","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479940953?lang=zh_cn&edition=full","pubTime":"2024-10-29 20:03","pubTimestamp":1730203380,"startTime":"0","endTime":"0","summary":"　　10月24日，诺泰生物公告称，近日收到中国证监会立案告知书，因涉嫌信息披露违法违规，公司及实控人之一赵德中被立案。　　同时公司表示，经公司自查，本次立案可能涉及公司 2021 年度技术转让相关事宜。　　资料显示，诺泰生物成立于2009年，2021年5月在科创板上市。　　对于诺泰生物及实控人被立案一事，浙江裕丰律师事务所厉健律师表示，根据证监会立案公告，诺泰生物及实控人涉嫌证券虚假陈述，受损投资者可依法索赔。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-10-29/doc-incufqpv7633739.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-10-29/doc-incufqpv7633739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2478101665","title":"“减肥药原料巨头”诺泰生物信披违规遭立案 第三季度业绩环比下滑揭示增长隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2478101665","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478101665?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:35","pubTimestamp":1730108100,"startTime":"0","endTime":"0","summary":"　　近日，江苏诺泰澳赛诺生物制药股份有限公司发布公告称，因涉嫌信息披露违法违规，公司及实际控制人之一赵德中于近日收到中国证监会的《立案告知书》。诺泰生物在公告中披露，经自查，其认为此次立案可能涉及诺泰生物2021年度技术转让相关事宜。但环比来看，诺泰生物第三季度的营收、净利分别环比下滑11.55%、23.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-10-28/doc-incuayyz8752005.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-10-28/doc-incuayyz8752005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2478122000","title":"诺泰生物10月28日遭主力抛售2620万元 环比增加111.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478122000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478122000?lang=zh_cn&edition=full","pubTime":"2024-10-28 15:19","pubTimestamp":1730099997,"startTime":"0","endTime":"0","summary":"10月28日, 诺泰生物股价跌1.14%，报收53.84元，成交金额5.82亿元，换手率4.93%，振幅5.09%，量比0.67。诺泰生物今日主力资金净流出2620万元，上一交易日主力净流出1239万元，今日环比增加111.46%。该股近5个交易日下跌15.36%，主力资金累计净流入9709万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出98万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028154501ab7a8d44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028154501ab7a8d44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2478848110","title":"诺泰生物（688076）被立案调查，股民索赔可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2478848110","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478848110?lang=zh_cn&edition=full","pubTime":"2024-10-28 10:04","pubTimestamp":1730081040,"startTime":"0","endTime":"0","summary":"　　2024年10月24日，江苏诺泰澳赛诺生物制药股份有限公司发布《关于公司及实际控制人之一收到中国证监会立案告知书的公告》，称因公司及实控人涉嫌信息披露违法违规，根据《证券法》《行政处罚法》等法律法规，中国证监会决定立案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-28/doc-incuakce3017753.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-28/doc-incuakce3017753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2478119962","title":"逼近20CM跌停！上周10家上市公司公告公司或相关方被证监会立案，热门芯片股盈方微在列","url":"https://stock-news.laohu8.com/highlight/detail?id=2478119962","media":"投资快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478119962?lang=zh_cn&edition=full","pubTime":"2024-10-28 08:58","pubTimestamp":1730077108,"startTime":"0","endTime":"0","summary":"盈方微10月23日公告，重组相关方人员因涉嫌泄露内幕信息被立案，上周累计10家上市公司公告公司或相关方被证监会立案(附表); 立案告知书给多股“当头一棒”，南卫股份、诺泰生物和中船应急公告次日分别收跌5.53%、8.11%和11.79%。SoC芯片设计企业盈方微10月23日公告，公司收到通知，本次重组相关方的相关人员因涉嫌泄露内幕信息被证监会出具《立案告知书》。目前公司尚未收到中国证监会的最终调查结论，经营情况正常。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028085949ab797c86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028085949ab797c86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0070","BK0198","BK0026","BK0125","BK0108","000670","159813","BK0214","BK0239","688076","BK0189","BK0109"],"gpt_icon":0},{"id":"2478310841","title":"诺泰生物：多肽产品持续放量 产能建设加快","url":"https://stock-news.laohu8.com/highlight/detail?id=2478310841","media":"国泰君安","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478310841?lang=zh_cn&edition=full","pubTime":"2024-10-28 00:00","pubTimestamp":1730044800,"startTime":"0","endTime":"0","summary":"考虑终端多肽产品需求超预期，自主产品持续放量，上调2024-2026 年EPS 预测为1.98/2.67/3.50 元，参考可比公司估值，给予2025 年PE27X，下调目标价至72.09元，维持“增持”评级。受多肽终端市场需求旺盛，报告期内多肽自主选择产品预计持续放量，收入占比提升。制剂端考虑奥司他韦胶囊Q3 需求淡季，营收预计环比下滑。中华药港制剂产能落地下，制剂业务有望持续放量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102818362495bd73ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102818362495bd73ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2478186273","title":"本周累计10家上市公司公告公司或相关方被立案 公告次日诺泰生物盘中逼近20CM跌停","url":"https://stock-news.laohu8.com/highlight/detail?id=2478186273","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478186273?lang=zh_cn&edition=full","pubTime":"2024-10-27 10:09","pubTimestamp":1729994986,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0070","BK0177","BK0188","BK0191","BK0125","BK0057","BK0168","BK0251","BK0108","BK0109","000952","600360","600079","BK0145","BK0037","BK0098","BK0086","BK0077","BK0239","BK0268","159982","BK0185","BK0012","000670","603880","BK0096","BK0026","399300","300998","BK0198","BK0214","BK0004","000793","000518","300527","BK0028","BK0189","688076","BK0046","BK0174"],"gpt_icon":0},{"id":"2478994360","title":"诺泰生物（688076）10月25日主力资金净卖出835.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478994360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478994360?lang=zh_cn&edition=full","pubTime":"2024-10-26 08:19","pubTimestamp":1729901970,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月25日收盘，诺泰生物报收于54.46元，下跌2.24%，换手率6.39%，成交量14.04万手，成交额7.66亿元。近5日资金流向一览见下表：诺泰生物融资融券信息显示，融资方面，当日融资买入6585.43万元，融资偿还6092.42万元，融资净买入493.01万元，连续3日净买入累计2904.02万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102600006837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2478072456","title":"或涉技术转让事宜，诺泰生物及实控人赵德中被立案，前三季度净利暴增超280%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478072456","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478072456?lang=zh_cn&edition=full","pubTime":"2024-10-25 18:47","pubTimestamp":1729853253,"startTime":"0","endTime":"0","summary":"因涉嫌信息披露违法违规等，多肽原料药龙头企业诺泰生物及其实控人之一赵德中被中国证监会立案。诺泰生物10月24日公告称，“经公司自查，本次立案可能涉及公司2021年度技术转让相关事宜。”诺泰生物的实际控制人为赵德毅、赵德中兄弟二人。就在诺泰生物及其实控人赵德中被立案的消息披露的前一天，诺泰生物刚刚公布了2024年三季报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025184818a1ea136a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025184818a1ea136a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-05-20","address":"江苏省连云港市连云区经济技术开发区临浦路28号","stockEarnings":[{"period":"1week","weight":0.0316},{"period":"1month","weight":-0.1298},{"period":"3month","weight":-0.1342},{"period":"6month","weight":-0.0375},{"period":"1year","weight":0.3029},{"period":"ytd","weight":0.2163}],"companyName":"江苏诺泰澳赛诺生物制药股份有限公司","boardCode":"AI0027","perCapita":"18852股","boardName":"医药制造业","registeredCapital":"21977万元","compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.0399},{"period":"3month","weight":0.1567},{"period":"6month","weight":0.056},{"period":"1year","weight":0.0917},{"period":"ytd","weight":0.1196}],"survey":"　　江苏诺泰澳赛诺生物制药股份有限公司是一家聚焦多肽药物及小分子化药进行自主研发与定制研发生产相结合的生物医药企业。公司的主要产品为阿托伐他汀钙片、氨氯地平阿托伐他汀钙片、利拉鲁肽、司美格鲁肽、苯甲酸阿格列汀、比伐芦定、依替巴肽、醋酸兰瑞肽、醋酸奥曲肽、磷酸奥司他韦、胸腺法新、GLP-1/GIP/GCG受体多靶点激动剂1类新药、氟维司群。","serverTime":1731737970928,"listedPrice":15.57,"stockholders":"11658人(较上一季度减少1.69%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺泰生物(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺泰生物(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺泰生物,688076,诺泰生物股票,诺泰生物股票老虎,诺泰生物股票老虎国际,诺泰生物行情,诺泰生物股票行情,诺泰生物股价,诺泰生物股市,诺泰生物股票价格,诺泰生物股票交易,诺泰生物股票购买,诺泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺泰生物(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺泰生物(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}